Compounds > darunavir
Page last updated: 2024-09-05

darunavir and ixazomib

darunavir has been researched along with ixazomib in 1 studies

Compound Research Comparison

Studies
(darunavir)		Trials
(darunavir)		Recent Studies (post-2010)
(darunavir)		Studies
(ixazomib)		Trials
(ixazomib)		Recent Studies (post-2010) (ixazomib)
1,14822478030078289

Protein Interaction Comparison

ProteinTaxonomydarunavir (IC50)ixazomib (IC50)
Proteasome subunit beta type-11Homo sapiens (human)0.015
Proteasome subunit alpha type-7Homo sapiens (human)0.015
Proteasome subunit beta type-1Homo sapiens (human)0.0163
Proteasome subunit alpha type-1Homo sapiens (human)0.015
Proteasome subunit alpha type-2Homo sapiens (human)0.015
Proteasome subunit alpha type-3Homo sapiens (human)0.015
Proteasome subunit alpha type-4Homo sapiens (human)0.015
Proteasome subunit beta type-8Homo sapiens (human)0.015
Proteasome subunit beta type-9Homo sapiens (human)0.015
Proteasome subunit alpha type-5Homo sapiens (human)0.015
Proteasome subunit beta type-4Homo sapiens (human)0.015
Proteasome subunit beta type-6Homo sapiens (human)0.015
Proteasome subunit beta type-5Homo sapiens (human)0.0065
Proteasome subunit beta type-10Homo sapiens (human)0.015
Proteasome subunit beta type-3Homo sapiens (human)0.015
Proteasome subunit beta type-2Homo sapiens (human)1.1817
Proteasome subunit alpha type-6Homo sapiens (human)0.015
ATP-dependent Clp protease proteolytic subunitStaphylococcus aureus subsp. aureus NCTC 83255.3
NACHT, LRR and PYD domains-containing protein 3 Mus musculus (house mouse)0.1995
Proteasome subunit alpha-type 8Homo sapiens (human)0.015
Proteasome subunit beta type-7Homo sapiens (human)0.015

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1

Other Studies

1 other study(ies) available for darunavir and ixazomib

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023